Thiothixene NDC 51407-278

NDC codes

FDA NDC Directory

Product NDC (as listed)51407-278Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51407-0278Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51407-278-01	51407027801	100 CAPSULE in 1 BOTTLE (51407-278-01)Marketed from Aug 20, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Thiothixene
Generic name (nonproprietary): thiothixene
Active ingredients: Thiothixene — 10 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Golden State Medical Supply, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211642
Marketing start: Apr 5, 2019
Listing expires: Dec 31, 2026
Identifiers: Product ID 51407-278_3284fb4d-549c-d0dc-e063-6394a90a8af4SPL ID 3284fb4d-549c-d0dc-e063-6394a90a8af4SPL set ID 9480a406-c85b-ba06-e053-2a95a90a0912RxCUI 313361, 313362, 313364, 313366UNII 7318FJ13YJ
Pharmacologic class: Typical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451407027801 followed by a unit qualifier and the quantity

Package 51407-0278-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 11, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS & USAGE Thiothixene capsules are effective in the management of schizophrenia. Thiothixene capsules have not been evaluated in the management of behavioral complications in patients with mental retardation.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)